Blogginlägget skrevs och publicerades av Kronan till Miljonen.
I det här inlägget tänkte jag kika lite mer på den amerikanska utdelningsjätten AbbVie som verkar inom hälsosektorn. Aktien har underpresterat mot S&P500 under de senaste åren men kanske finns det nu köpläge? Inlägget AbbVie analys – köpvärt 2022 dök först upp på KRONAN TILL MILJONEN.
Länk till hela inlägget hos Kronan till Miljonen: AbbVie analys – köpvärt 2022
| Cookie | Varaktighet | Beskrivning |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
